Effect of dimebon on NMDA-activated current in mice medium spiny neuron
Author(s): XU Xiao-li, LI Qin, SONG Lu
Pages: 89-92
Year: 2015 Issue: 1
Journal: Chinese Journal of Clinical Anatomy
Keyword: Medium spiny striatal neurons; NMDA receptor;
Abstract: Objective Dimebon is an antihistamine compound which has been proposed to treat neurodegenerative disorders, but the mechanism remain elusive. To explore Dimebon effection on Alzheimer's disease and Huntington's disease. Method Membrane currents were measured by using whole cell patch clamp techniques. the influence ofdifferent concentration of Dimebon on NMDA-activated currents in primary Medium Spiny Striatal Neuronal cultures (MSN) from wild type (WT) mice were studied. Results 1~50 μmol/L Dimebon inhibited NMDA activated currents, but 0.1~0.5μmol/L increased NMDA activated currents. Conclusion Dimebon has dual function on NMDA receptors.
Pages: 89-92
Year: 2015 Issue: 1
Journal: Chinese Journal of Clinical Anatomy
Keyword: Medium spiny striatal neurons; NMDA receptor;
Abstract: Objective Dimebon is an antihistamine compound which has been proposed to treat neurodegenerative disorders, but the mechanism remain elusive. To explore Dimebon effection on Alzheimer's disease and Huntington's disease. Method Membrane currents were measured by using whole cell patch clamp techniques. the influence ofdifferent concentration of Dimebon on NMDA-activated currents in primary Medium Spiny Striatal Neuronal cultures (MSN) from wild type (WT) mice were studied. Results 1~50 μmol/L Dimebon inhibited NMDA activated currents, but 0.1~0.5μmol/L increased NMDA activated currents. Conclusion Dimebon has dual function on NMDA receptors.
Related Articles